Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Gloversville › NPI 1336145168
Hospital

Nathan Littauer Hospital Association

Nathan Littauer Hospital Association was paid $13.87M by Medicaid between Sep 2018 and Dec 2024, across 274 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

33Billing provider infoNATHAN LITTAUER HOSPITAL ASSOCIATION
GLOVERSVILLE, NY 12078
33aNPI1336145168assigned 06/27/2005
33bProvider typeRural Acute Care Hospital
28Total paid$13.87M
24GClaims504,400
24DCodes billed274
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in New York

Rank by total paid#4 of 7
Median peer was paid$13.87M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201851$2K
201929,141$835K
202080,648$1.97M
202189,481$2.43M
2022103,725$2.90M
2023112,261$3.17M
2024incomplete89,093$2.57M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 11,327 10,977 $1.46M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.6% 10,953 10,365 $1.34M
41899 Unlisted procedure, dentoalveolar structures 8.3% 1,050 1,046 $1.15M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.6% 7,350 7,114 $914K
74177 Computed tomography, abdomen and pelvis; with contrast material 6.5% 3,336 3,268 $897K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.2% 5,899 5,667 $725K
70450 Computed tomography, head or brain; without contrast material 4.4% 2,340 2,284 $612K
80053 Comprehensive metabolic panel 3.8% 31,995 29,152 $526K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.7% 4,856 4,675 $369K
45380 Colonoscopy, flexible; with biopsy, single or multiple 2.4% 618 617 $338K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.4% 972 969 $336K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.0% 1,953 1,408 $282K
262 more codes
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.0% 4,658 $276K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.8% 931 $247K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.5% 1,615 $209K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 5,161 $204K
71275 Computed tomographic angiography, chest, with contrast material 1.4% 709 $198K
77067 Screening mammography, bilateral, including computer-aided detection 1.3% 2,023 $186K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.2% 7,396 $166K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.2% 5,426 $161K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.1% 7,399 $157K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,344 $117K
36415 Collection of venous blood by venipuncture <1% 26,258 $104K
84443 Thyroid stimulating hormone (TSH) <1% 11,535 $95K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 487 $94K
88142 <1% 3,600 $77K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 594 $76K
80061 Lipid panel <1% 12,082 $76K
12001 <1% 186 $74K
76830 Ultrasound, transvaginal <1% 1,745 $69K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 35,708 $69K
83036 Hemoglobin; glycosylated (A1C) <1% 7,408 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,331 $66K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,560 $64K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 179 $59K
80048 Basic metabolic panel (calcium, ionized) <1% 4,909 $56K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,578 $54K
96361 Intravenous infusion, hydration; each additional hour <1% 308 $53K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 677 $51K
83880 <1% 1,593 $49K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,687 $48K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,693 $46K
87088 <1% 7,955 $45K
83655 <1% 3,549 $45K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 2,381 $43K
82607 <1% 3,472 $42K
86850 <1% 2,071 $39K
87070 <1% 7,643 $38K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,065 $38K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 123 $37K
84439 <1% 4,413 $37K
82728 <1% 2,821 $35K
G0378 Hospital observation service, per hour <1% 660 $34K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 44 $34K
99214 Doctor's office visit, returning patient (more involved) <1% 487 $33K
71046 Radiologic examination, chest; 2 views <1% 4,745 $29K
93971 <1% 531 $28K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 923 $28K
84153 <1% 1,397 $26K
S5161 Emergency response system; service fee, per month (excludes installation and testing) <1% 769 $26K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 290 $26K
76801 <1% 534 $25K
82746 <1% 2,046 $24K
86901 <1% 1,309 $24K
86803 <1% 2,413 $23K
88342 <1% 351 $23K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 614 $22K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,006 $20K
59025 Fetal non-stress test <1% 132 $19K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,705 $19K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,360 $18K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 558 $18K
86900 <1% 1,317 $18K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 614 $18K
99213 Doctor's office visit, returning patient (routine) <1% 166 $18K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 246 $17K
70486 <1% 246 $17K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,250 $16K
97162 <1% 182 $16K
84702 <1% 2,597 $16K
86762 <1% 1,110 $16K
29125 <1% 78 $15K
83540 <1% 3,171 $15K
90715 <1% 523 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,882 $14K
82784 <1% 1,013 $14K
87077 <1% 2,467 $14K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 500 $12K
97161 <1% 154 $12K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 319 $12K
29515 <1% 60 $12K
11721 <1% 636 $11K
85027 <1% 3,777 $11K
81001 <1% 13,112 $11K
81025 <1% 3,360 $11K
87081 <1% 2,306 $10K
71250 <1% 91 $10K
72110 <1% 714 $10K
83550 <1% 1,994 $10K
87481 <1% 452 $9K
86787 <1% 1,171 $9K
80076 <1% 1,036 $9K
86003 <1% 131 $9K
94060 <1% 51 $9K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 150 $9K
83735 <1% 6,081 $9K
V2632 Posterior chamber intraocular lens <1% 107 $9K
71271 <1% 223 $9K
86592 <1% 2,598 $8K
86140 <1% 3,021 $8K
87341 <1% 843 $8K
86618 <1% 632 $8K
70551 Magnetic resonance imaging, brain; without contrast material <1% 26 $8K
72125 Computed tomography, cervical spine; without contrast material <1% 244 $8K
64483 <1% 12 $8K
76536 <1% 361 $8K
76770 <1% 100 $7K
85610 <1% 3,747 $7K
82043 <1% 1,367 $6K
12002 <1% 15 $6K
86038 <1% 1,274 $6K
76642 <1% 216 $6K
87428 <1% 516 $5K
86777 <1% 371 $5K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 15 $5K
83970 <1% 139 $5K
86617 <1% 294 $5K
86778 <1% 372 $5K
73630 <1% 1,443 $5K
73221 <1% 13 $4K
73562 <1% 994 $4K
12011 <1% 13 $4K
83690 <1% 5,863 $4K
82570 <1% 900 $4K
85652 <1% 2,816 $4K
84703 <1% 3,663 $4K
88304 <1% 107 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,211 $4K
87807 <1% 646 $4K
84402 <1% 142 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 26 $4K
87340 <1% 310 $3K
82950 <1% 658 $3K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,686 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,206 $3K
95806 <1% 68 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 97 $3K
85007 <1% 2,573 $3K
86376 <1% 189 $3K
80069 <1% 301 $3K
85730 <1% 1,820 $3K
80306 <1% 1,228 $3K
73610 <1% 1,151 $2K
84450 <1% 460 $2K
73030 <1% 617 $2K
84460 <1% 459 $2K
73130 <1% 925 $2K
86665 <1% 98 $2K
84484 <1% 6,811 $2K
82550 <1% 2,825 $2K
84436 <1% 365 $2K
87205 <1% 951 $2K
93242 <1% 12 $2K
84403 <1% 66 $2K
74019 <1% 260 $2K
93880 <1% 14 $2K
86431 <1% 351 $2K
81003 <1% 1,379 $2K
86235 <1% 86 $2K
71045 Radiologic examination, chest; single view <1% 5,497 $2K
96367 <1% 41 $2K
83002 <1% 87 $2K
84560 <1% 363 $2K
85379 <1% 2,003 $1K
84481 <1% 170 $1K
86255 <1% 106 $1K
86480 <1% 25 $1K
84146 <1% 56 $1K
85014 <1% 595 $1K
85018 <1% 583 $1K
83001 <1% 56 $1K
73110 <1% 429 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 783 $1K
87046 <1% 258 $1K
87040 <1% 2,475 $1K
87177 <1% 204 $959.91
87045 <1% 258 $953.55
86403 <1% 2,108 $908.55
84156 <1% 276 $859.02
86666 <1% 51 $835.39
96375 Therapeutic injection; each additional sequential IV push <1% 4,238 $820.27
86141 <1% 78 $802.12
86430 <1% 164 $780.80
86696 <1% 52 $757.30
81511 <1% 12 $750.80
82150 <1% 255 $738.92
76775 <1% 25 $714.48
0012A <1% 44 $697.36
0064A <1% 16 $686.80
86704 <1% 75 $678.39
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,048 $646.38
0011A <1% 46 $628.44
82553 <1% 1,424 $573.69
86706 <1% 52 $530.71
74018 <1% 222 $485.75
83605 <1% 1,967 $482.21
85651 <1% 360 $476.05
86160 <1% 28 $445.62
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 681 $430.90
86701 <1% 44 $424.71
86308 <1% 160 $377.55
88300 <1% 603 $344.79
90686 <1% 14 $315.97
83525 <1% 26 $311.09
90688 <1% 16 $286.79
J2704 Injection, propofol, 10 mg <1% 4,137 $276.58
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,458 $241.91
J3490 Unclassified drugs <1% 15 $228.47
82248 <1% 56 $227.85
82270 <1% 102 $218.81
94761 <1% 851 $210.00
87400 <1% 1,013 $199.32
J0690 Injection, cefazolin sodium, 500 mg <1% 734 $194.37
82465 <1% 39 $178.16
A9585 Injection, gadobutrol, 0.1 ml <1% 140 $176.17
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 18 $160.48
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,000 $156.80
87209 <1% 58 $152.10
82565 <1% 36 $144.18
80050 General health panel <1% 935 $141.51
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,390 $127.86
86708 <1% 12 $121.50
72050 <1% 12 $121.20
73502 <1% 24 $109.21
87324 <1% 59 $103.40
73080 <1% 43 $95.40
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 936 $83.85
84479 <1% 26 $83.25
C9399 Unclassified drugs or biologicals <1% 387 $68.72
70360 <1% 12 $68.08
96376 <1% 1,266 $67.38
86694 <1% 12 $62.40
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 164 $61.73
83718 <1% 12 $60.36
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,082 $59.77
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 684 $52.18
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,348 $51.99
83615 <1% 54 $50.30
89055 <1% 31 $44.20
84520 <1% 12 $43.45
J1170 Injection, hydromorphone, up to 4 mg <1% 318 $41.22
73590 <1% 12 $36.00
94726 <1% 14 $33.98
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 561 $23.52
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 822 $22.69
73140 <1% 28 $18.20
82077 <1% 47 $17.27
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,067 $15.37
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 33 $14.40
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,500 $14.39
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,027 $14.14
85384 <1% 43 $6.90
J2060 Injection, lorazepam, 2 mg <1% 140 $5.80
J7510 Prednisolone oral, per 5 mg <1% 179 $1.11
C9113 Injection, pantoprazole sodium, per vial <1% 87 $1.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 13 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 52 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 23 $0.00
88312 0% 61 $0.00
A4649 Surgical supply; miscellaneous 0% 36 $0.00
80179 0% 12 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 12 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOSTRANDER, MICHAEL (VP FINANCE & CFO)